title: NICE uses wrong comparator to assess cost effectiveness of new drugs, report says.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods*; D006077:Government Agencies; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D006113:United Kingdom
chemical_list: D004364:Pharmaceutical Preparations